Neuronetics, Inc.

Neuronetics, Inc.

$2.61
0.09 (3.57%)
NASDAQ
USD, US
Medical - Diagnostics & Research

52 Week Range

1.03-5.07

Beta

2.5

Market Cap

$78.29M

Last Dividend

0

PE (TTM)

-2.79

Dividend Yield (TTM)

0

Price Chart

Industry

Medical - Diagnostics & Research

Sector

Healthcare

CEO

Mr. Keith J. Sullivan

Full-Time Employees

203

IPO Date

2018-06-28

Description

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Phone

610 640 4202

Address

3222 Phoenixville Pike, Malvern, PA, 19355, US

CIK

0001227636